MONA BAKSHI: Open Payments
NPI 1043431554 · VALLEY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 23 payments from 10 companies in 2025. Trend: 2023 $690 · 2024 $449 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $144 |
| Novo Nordisk Inc | 5 | $84 |
| GlaxoSmithKline, LLC. | 4 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
| PFIZER INC. | 2 | $41 |
| Viatris Specialty LLC | 1 | $23 |
| ABBVIE INC. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
| Paratek Pharmaceuticals, Inc. | 1 | $16 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: BREZTRI, Wegovy, CAPLYTA, TRELEGY ELLIPTA, NURTEC ODT, AIRSUPRA, Rybelsus, YUPELRI.
Industry payments across AL — which companies pay providers there.
